|
|
40
|
|
|
0381Q
|
|
|
RIFAMPICIN 300MG CAP (MCP/AHI)
|
|
|
RIFAMPICIN
|
|
|
RIFAMPICIN
|
|
|
10X10
|
|
|
A
|
|
|
68.96
|
|
|
0.69
|
|
|
300MG
|
|
|
CAPSULE
|
|
|
60
|
|
|
CAP
|
|
|
MCP
|
|
|
MACLEODS PHARMACEUTICALS LTD
|
|
|
AHI
|
|
|
ARMSTRONG HEALTHCARE INC
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No
|
|
|
081604
|
|
|
ANTITUBERCULOSIS AGENTS
|
|
|
|
|
|
Oral
|
|
|
6
|
|
|
ANTI-INFECTIVE AGENTS
|
|
|
|